Microtubule-Associated Protein 2, a Marker of Neuronal Differentiation, Induces Mitotic Defects, Inhibits Growth of Melanoma Cells, and Predicts Metastatic Potential of Cutaneous Melanoma
- 1 June 2005
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 166 (6) , 1841-1850
- https://doi.org/10.1016/s0002-9440(10)62493-5
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Thin MelanomasAnnals of Surgery, 2003
- Microtubules are the only structural constituent of the spindle apparatus required for induction of cell cleavageThe Journal of cell biology, 2003
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Transforming properties of a Q18→E mutation of the microtubule regulator Op18Cancer Cell, 2002
- Regulated Association of Microtubule-associated Protein 2 (MAP2) with Src and Grb2: Evidence for MAP2 as a Scaffolding ProteinJournal of Biological Chemistry, 2000
- A New Look at Nevus-Associated MelanomasThe American Journal of Dermatopathology, 1996
- Karyometry of Primary and Metastatic Malignant MelanomaThe American Journal of Dermatopathology, 1994
- Nuclear Indices and Survival in Cutaneous MelanomaThe American Journal of Dermatopathology, 1989
- Differential utilization of beta-tubulin isotypes in differentiating neurites.The Journal of cell biology, 1989
- Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factorsInternational Journal of Cancer, 1987